Current Volume 13(1) 2008 Supl. (48)

01 Dec 2007   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, [...] K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger - Show fewer authors

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

01 Dec 2007   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

01 Dec 2007   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, [...] J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten - Show fewer authors

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

01 Dec 2007   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, [...] C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi - Show fewer authors

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

01 Dec 2007   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, [...] P. Glander, W. Weimar, T. van Gelder - Show fewer authors

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

01 Dec 2007   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, [...] Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht - Show fewer authors

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

01 Dec 2007   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, [...] B. Gutkowska, F. Herold - Show fewer authors

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

01 Dec 2007   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, [...] M. Głyda, N. Wachowiak - Show fewer authors

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

01 Dec 2007   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, [...] B. Jedlickova, J. Segethova - Show fewer authors

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

01 Dec 2007   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, [...] A. Fasth, C. E. Staatz - Show fewer authors

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

01 Dec 2007   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, [...] E. Ignacak, J. W. Naskalski - Show fewer authors

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

01 Dec 2007   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, [...] M. Boratyńska, K. Falkiewicz, M. Klinger - Show fewer authors

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

01 Dec 2007   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, [...] M. Outeda Macías, I. Martín Herranz - Show fewer authors

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

01 Dec 2007   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, [...] K. Tentschert, A. Griesmacher - Show fewer authors

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

01 Dec 2007   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, [...] H. Ait-Youcef - Show fewer authors

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

01 Dec 2007   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, [...] S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring - Show fewer authors

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

01 Dec 2007   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, [...] D. Blake, T. Drury, M. Ehrdhard - Show fewer authors

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

01 Dec 2007   

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, [...] V. Bodepudi, R. Loor, J. Zonderman - Show fewer authors

Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

01 Dec 2007   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, [...] C. E. Gonde, M. Pires, J. Tracey, M. Tredger - Show fewer authors

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

29 Sep 2008   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

01 Dec 2007   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, [...] K. Verbeke, Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

01 Dec 2007   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, [...] C. Kodzu, Y. Ijiri, K. Tanaka - Show fewer authors

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

01 Dec 2007   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, [...] Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

01 Dec 2007   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, [...] Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

01 Dec 2007   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, [...] F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro - Show fewer authors

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

01 Jan 2008 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

239 0

01 Jan 2008 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, [...] K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger - Show fewer authors

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

237 0

01 Jan 2008 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, [...] C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi - Show fewer authors

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

257 0

01 Jan 2008 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, [...] J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten - Show fewer authors

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

260 0

01 Jan 2008 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, [...] Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht - Show fewer authors

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

299 0

01 Jan 2008 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, [...] P. Glander, W. Weimar, T. van Gelder - Show fewer authors

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

238 0

01 Jan 2008 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, [...] B. Jedlickova, J. Segethova - Show fewer authors

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

248 0

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, [...] M. Głyda, N. Wachowiak - Show fewer authors

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

229 0

01 Jan 2008 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, [...] B. Gutkowska, F. Herold - Show fewer authors

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

255 0

01 Jan 2008 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, [...] A. Fasth, C. E. Staatz - Show fewer authors

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

246 0

01 Jan 2008 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, [...] E. Ignacak, J. W. Naskalski - Show fewer authors

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

254 0

01 Jan 2008 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, [...] K. Tentschert, A. Griesmacher - Show fewer authors

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

255 0

01 Jan 2008 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, [...] M. Outeda Macías, I. Martín Herranz - Show fewer authors

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

213 0

01 Jan 2008 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, [...] M. Boratyńska, K. Falkiewicz, M. Klinger - Show fewer authors

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

239 0

01 Jan 2008 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, [...] S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring - Show fewer authors

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

301 0

01 Jan 2008 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, [...] H. Ait-Youcef - Show fewer authors

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

272 0

01 Jan 2008 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, [...] C. E. Gonde, M. Pires, J. Tracey, M. Tredger - Show fewer authors

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

292 0

01 Jan 2008 :   

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, [...] V. Bodepudi, R. Loor, J. Zonderman - Show fewer authors

Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

242 0

01 Jan 2008 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, [...] D. Blake, T. Drury, M. Ehrdhard - Show fewer authors

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

225 0

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

238 0

01 Jan 2008 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, [...] K. Verbeke, Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

246 0

01 Jan 2008 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, [...] C. Kodzu, Y. Ijiri, K. Tanaka - Show fewer authors

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

246 0

01 Jan 2008 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, [...] Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

255 0

01 Jan 2008 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, [...] Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

300 0

01 Jan 2008 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, [...] F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro - Show fewer authors

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

238 0

01 Jan 2008 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

256 0

01 Jan 2008 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

231 0

01 Jan 2008 :   

Generic products – requirements for drug registration

P. K. Kunicki,

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

216 0

01 Jan 2008 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

228 0

01 Jan 2008 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

245 0

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients

T. van Gelde,

Ann Transplant 2008; 13(1): 27-27 :: ID: 880181

225 0

01 Jan 2008 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

226 0

01 Jan 2008 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

229 0

01 Jan 2008 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

247 0

01 Jan 2008 :   

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine

L. M. Shaw, M. Figurski, [...] M. D. Pescovitz - Show fewer authors

Ann Transplant 2008; 13(1): 23-23 :: ID: 880177

229 0

01 Jan 2008 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

282 0

01 Jan 2008 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

215 0

01 Jan 2008 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

252 0

01 Jan 2008 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka,

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

201 0

01 Jan 2008 :   

Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs

P. J. Taylor,

Ann Transplant 2008; 13(1): 18-18 :: ID: 880172

385 0

01 Jan 2008 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

300 0

01 Jan 2008 :   

PK/PD modelling of immunosuppressive agents

E. Wyska,

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

300 0

01 Jan 2008 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

190 0

01 Jan 2008 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

316 0

01 Jan 2008 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

257 0

01 Jan 2008 :   

Clinical immunosuppression – current status

M. Klinger,

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

283 0

01 Jan 2008 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

269 0

01 Jan 2008 :   

Organ transplantation in Poland

M. Durlik,

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

287 0